The Sabol business group is expanding its operations internationally, venturing into medicine manufacturing in Saudi Arabia and biofuels in Indonesia and the Emirates, while also expressing concerns over Slovakia's tax policies.
The Sabol business group, helmed by Ján Sabol, is significantly expanding its international presence, with ventures into the pharmaceutical sector in Saudi Arabia and biofuel production in Indonesia and the Emirates. This expansion follows successful operations in Brazil and India, and marks the group's entry into the U.S. market, showcasing a diversification of their business interests beyond Slovakia.
Despite these global aspirations, the Sabol group continues to maintain a robust presence in Slovakia, where it closely monitors developments in the country's tax policy. The group's co-owner and top executive, Robert Spišák, has expressed concern over the current tax climate, likening it to the historical practices of Hungarian aristocrat Matúš Čak Trenčiansky, who was known for aggressively collecting resources during feasts. Spišák argues that this current approach contrasts sharply with the more rational economic policies Slovakia had under former Prime Minister Mikuláš Dzurinda.
In a recent interview with Denník E, Spišák discussed the group's future growth, emphasizing the potential of biofuels even with the rise of electric vehicles. The interview indicates that Sabol and his affiliates are positioning themselves to adapt to emerging market trends while also safeguarding their interests within Slovakia amidst a shifting economic landscape.
